Avity Investment Management’s AbbVie ABBV Stock Holding History

Avity Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$839K	Sell	3,333 -3	-0.1%	-$645	0.05%	74
2026 Q1	$726K	Hold	3,336	–	–	0.05%	74
2025 Q4	$762K	Hold	3,336	–	–	0.05%	70
2025 Q3	$772K	Sell	3,336 -193	-5%	-$39.3K	0.05%	70
2025 Q2	$655K	Sell	3,529 -50	-1%	-$9.29K	0.05%	70
2025 Q1	$750K	Buy	3,579 +400	+13%	+$77.8K	0.06%	65
2024 Q4	$565K	Hold	3,179	–	–	0.04%	70
2024 Q3	$628K	Sell	3,179 -264	-8%	-$49.3K	0.05%	67
2024 Q2	$591K	Sell	3,443 -5	-0.1%	-$828	0.05%	60
2024 Q1	$628K	Buy	3,448 +170	+5%	+$29.3K	0.05%	63
2023 Q4	$508K	Hold	3,278	–	–	0.05%	62
2023 Q3	$489K	Sell	3,278 -200	-6%	-$29.4K	0.05%	57
2023 Q2	$469K	Sell	3,478 -1,203	-26%	-$176K	0.04%	64
2023 Q1	$746K	Sell	4,681 -245	-5%	-$37.5K	0.07%	55
2022 Q4	$796K	Sell	4,926 -200	-4%	-$30.7K	0.08%	53
2022 Q3	$688K	Buy	5,126 +550	+12%	+$78.9K	0.07%	51
2022 Q2	$701K	Buy	4,576 +500	+12%	+$76.4K	0.07%	53
2022 Q1	$661K	Hold	4,076	–	–	0.06%	55
2021 Q4	$552K	Hold	4,076	–	–	0.04%	55
2021 Q3	$440K	Hold	4,076	–	–	0.04%	61
2021 Q2	$459K	Sell	4,076 -143	-3%	-$16.1K	0.04%	59
2021 Q1	$457K	Hold	4,219	–	–	0.04%	54
2020 Q4	$452K	Sell	4,219 -372	-8%	-$35.7K	0.04%	52
2020 Q3	$402K	Hold	4,591	–	–	0.04%	51
2020 Q2	$451K	Buy	4,591 +3	+0.1%	+$264	0.05%	47
2020 Q1	$350K	Sell	4,588 -800	-15%	-$68.1K	0.05%	48
2019 Q4	$477K	Sell	5,388 -465	-8%	-$38.6K	0.05%	50
2019 Q3	$443K	Hold	5,853	–	–	0.05%	49
2019 Q2	$426K	Hold	5,853	–	–	0.05%	50
2019 Q1	$472K	Hold	5,853	–	–	0.06%	48
2018 Q4	$540K	Hold	5,853	–	–	0.08%	46
2018 Q3	$554K	Sell	5,853 -1,929	-25%	-$183K	0.07%	46
2018 Q2	$721K	Sell	7,782 -1	-0%	-$98	0.09%	42
2018 Q1	$737K	Sell	7,783 -1,200	-13%	-$132K	0.1%	43
2017 Q4	$869K	Buy	8,983 +1,400	+18%	+$132K	0.11%	41
2017 Q3	$674K	Hold	7,583	–	–	0.09%	43
2017 Q2	$550K	Hold	7,583	–	–	0.07%	50
2017 Q1	$494K	Hold	7,583	–	–	0.07%	50
2016 Q4	$475K	Sell	7,583 -203	-3%	-$12.4K	0.07%	49
2016 Q3	$493K	Hold	7,786	–	–	0.08%	50
2016 Q2	$482K	Buy	7,786 +500	+7%	+$30.5K	0.08%	50
2016 Q1	$434K	Hold	7,286	–	–	0.07%	53
2015 Q4	$432K	Buy	7,286 +1,300	+22%	+$74.9K	0.07%	55
2015 Q3	$322K	Hold	5,986	–	–	0.05%	56
2015 Q2	$402K	Buy	5,986 +286	+5%	+$18.7K	0.06%	57
2015 Q1	$362K	Sell	5,700 -1,400	-20%	-$84.6K	0.06%	57
2014 Q4	$465K	Hold	7,100	–	–	0.07%	52
2014 Q3	$410K	Hold	7,100	–	–	0.07%	53
2014 Q2	$401K	Sell	7,100 -1,350	-16%	-$70.8K	0.07%	55
2014 Q1	$434K	Sell	8,450 -250	-3%	-$12.6K	0.08%	45
2013 Q4	$459K	Hold	8,700	–	–	0.09%	45
2013 Q3	$389K	Hold	8,700	–	–	0.08%	46
2013 Q2	$360K	Buy	+8,700	New	+$380K	0.08%	49

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Avity Investment Management's ABBV Position: Q2 2026 in Review

Avity Investment Management reduced its AbbVie (ABBV) stake by 0.09% in Q2 2026, selling an estimated $645 and leaving 3,333 shares worth $839K. The position accounts for 0.05% of the portfolio, ranked #74.

Avity Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $869K in Q4 2017. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Avity Investment Management held 3,333 shares of AbbVie worth $839K as of Q2 2026.
Avity Investment Management sold 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.05% of Avity Investment Management's portfolio in Q2 2026, its #74 holding.
Avity Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Avity Investment Management's AbbVie position peaked at $869K in Q4 2017.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Avity Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.